Form 4: Cadre Holdings Director William Quigley III Granted 16,000 Stock Options
Insider Transaction Report
Cadre Holdings, Inc. Director William G. Quigley III was granted 16,000 stock options with an exercise price of $32.77, vesting quarterly over the next year.
Summary
- William G. Quigley III, a Director of Cadre Holdings, Inc. (CDRE), was granted 16,000 stock options.
- The options have an exercise price of $32.77 per share.
- The grant date for these options was May 30, 2025, and they expire on May 30, 2035.
- The options were granted under the Issuer's 2021 Stock Incentive Plan.
- The options will vest in four equal consecutive quarterly tranches of 4,000 shares each.
- Vesting dates are scheduled for June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026.
Sentiment
Score: 7
Explanation: The sentiment is positive as the grant of stock options aligns the director's interests with shareholder value, which is generally viewed favorably. However, it is a routine compensation event rather than a significant operational or financial announcement.
Positives
- The grant of stock options aligns the director's financial interests with the long-term performance and shareholder value creation of Cadre Holdings, Inc.
- It serves as an incentive for the director to contribute to the company's growth and profitability.
Negatives
- No direct negatives are indicated by this routine compensation filing.
Risks
- The value of the stock options is directly tied to the future market price of Cadre Holdings, Inc. common stock, meaning they could become worthless if the stock price falls below the exercise price.
- Market volatility could impact the perceived and actual value of this compensation.
Future Outlook
The grant of stock options indicates a long-term incentive for the director, aligning their future financial gains with the company's stock performance and strategic objectives over the next decade.
Industry Context
The granting of stock options to directors is a common practice in publicly traded companies across various industries, serving as a key component of executive and director compensation packages to incentivize performance and align interests with shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Structure | Grant of stock options under the Issuer's 2021 Stock Incentive Plan, indicating the continued use of equity-based compensation for directors. | 05/30/2025 | Reinforces alignment of director incentives with long-term shareholder value. |
Stakeholder Impact
- Shareholders: The grant of options aims to align the director's interests with shareholder value creation, potentially leading to better governance and performance.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- Monitoring the vesting of the stock options on June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026.
- Potential exercise of options by the director at any point after vesting and before the expiration date of May 30, 2035.
Key Dates
| Date | Description |
|---|---|
| 05/30/2025 | Date of earliest transaction (grant date of stock options) |
| 06/30/2025 | First quarterly vesting tranche of 4,000 shares |
| 09/30/2025 | Second quarterly vesting tranche of 4,000 shares |
| 12/31/2025 | Third quarterly vesting tranche of 4,000 shares |
| 03/31/2026 | Fourth and final quarterly vesting tranche of 4,000 shares |
| 05/30/2035 | Expiration date of the stock options |
| 06/03/2025 | Signature date of the reporting person on the Form 4 |
Recommendation
holdKeywords
Cadre Holdings, CDRE, stock options, insider transaction, Form 4, executive compensation, equity grant, William Quigley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.